BOSTON, June 05, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, chairman and chief executive officer and David Henry, chief financial officer, will present and host one-on-one meetings with investors at the Sidoti Virtual Investor conference being held on June 12-13, 2024.
On May 29, 2024, Thomas Kirk, Director at Myomo Inc (MYO), purchased 50,000 shares of the company, as reported in the SEC Filing.
On May 15, 2024, Harry Kovelman, Chief Medical Officer of Myomo Inc (MYO), executed a sale of 35,426 shares of the company.